Addition of Hydroxyurea to Fludarabine, Cytarabine, Idarubicin and Venetoclax Salvage Therapy for Adults With Relapsed or Refractory Acute Myeloid Leukemia
Clinical trial NCT07766850 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07766850
- Sponsor
- Christer C Nilsson
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-10-01
- Primary completion
- 2029-06-01
- Enrollment
- 26
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.